Sasaki Hirofumi, Ikeuchi Hiroki, Bando Toshihiro, Hirose Kei, Hirata Akihiro, Chohno Teruhiro, Horio Yuki, Tomita Naohiro, Hirota Seiichi, Ide Yoshihiro, Tsuchida Yasuaki, Uchino Motoi
Departments of Inflammatory Bowel Disease, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan.
Departments of Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
Surg Today. 2017 Jan;47(1):35-41. doi: 10.1007/s00595-016-1336-2. Epub 2016 Apr 19.
We examined the clinicopathological characteristics and prognosis of patients with cancer associated with Crohn's disease (CD).
The subjects of this study were patients with cancer confirmed in a resected specimen of bowel, who were treated at our institution between September, 1974 and December, 2014.
We analyzed 34 patients (26 men, 8 women, median age at cancer diagnosis 43.5 years, duration of illness 18 years) and found that the number of those with CD complicated with cancer began to drastically increase after 2005. The site of onset of cancer was in an anorectal lesion in 24 (70.6 %) patients. In 17 (50 %) patients, the cancer was diagnosed before surgery; in 3 patients (8.8 %), it was based on pathological findings during surgery; and in 14 patients (41.2 %), it was based on postoperative pathological findings. Mucinous carcinoma was the dominant histological type, seen in 15 patients (44.1 %), while the special type of signet-ring cell carcinoma was found in 4 patients. The cumulative overall 5 year survival rate was 46.2 %.
In this group of Japanese CD patients, an anorectal lesion was the most frequent site of origin of cancer. As cancer was diagnosed preoperatively in only 50 % of these patients, the overall prognosis was poor, with a cumulative 5 year survival rate of just 46.2 %.
我们研究了克罗恩病(CD)相关癌症患者的临床病理特征及预后。
本研究的对象为在我院接受治疗、经肠切除标本确诊为癌症的患者,时间跨度为1974年9月至2014年12月。
我们分析了34例患者(男性26例,女性8例,癌症诊断时的中位年龄为43.5岁,病程18年),发现2005年后CD合并癌症的患者数量开始急剧增加。癌症的发病部位在24例(70.6%)患者中为肛肠病变。17例(50%)患者在手术前被诊断出癌症;3例(8.8%)基于手术中的病理发现;14例(41.2%)基于术后病理发现。黏液癌是主要的组织学类型,见于15例患者(44.1%),而特殊类型的印戒细胞癌见于4例患者。累计5年总生存率为46.2%。
在这组日本CD患者中,肛肠病变是癌症最常见的起源部位。由于这些患者中只有50%在术前被诊断出癌症,总体预后较差,累计5年生存率仅为46.2%。